Will This Cause HEXO to Dominate the Market?

: hexo | HEXO Corp. Common Shares News, Ratings, and Charts

hexo – In recent news, there have been rumors spread around the internet that HEXO could potentially be eyeing CannTrust as an acquisition target.

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

In recent news, there have been rumors spread around the internet that HEXO Corp. (HEXO - Get Rating) could potentially be eyeing CannTrust as an acquisition target. We noticed a spike this past Friday in shares of both companies moving in tandem within the last two hours of trade with CannTrust clearly outperforming closing the day up 40%. This comes after a rumor was leaked that Aleafia health was staging a hostile takeover bid. We feel that in this case, HEXO Corp. (HEXO - Get Rating) has a lot to gain from acquiring a company like CannTrust and we are going to explain why.

HEXO is well known for its joint venture with Molson Coors Canada that is focused on non-alcoholic, cannabis-infused beverages. Molson Coors Canada has a 57.5% controlling interest in Truss, their joint venture, with HEXO Corp. (HEXO - Get Rating) having the remaining ownership interest (42.5%). This is old news, but I wanted to point out how important it is to have a joint venture or strategic partnership. We feel that this is one big reason that sets HEXO Corp. (HEXO - Get Rating) apart from the rest of the companies, but where HEXO Corp. (HEXO - Get Rating) falls short is production capacity. Currently, HEXO Corp. (HEXO - Get Rating) will be set to produce 150,000 kgs when all of their newly acquired New Strike Brands facilities are operating at full capacity. 150,000 kgs per year is a decent production capacity for a company the size of HEXO Corp. (HEXO - Get Rating) but many of HEXO’s competitors will produce much more cannabis. With that being said, production capacity is not everything, just like when comparing cars, just because one car has more horsepower does not always mean that it will be the fastest, there are many other factors to take into account. We feel that having a strong distribution network that allows for rapid and scalable distribution is a lot harder to build as opposed to production capacity alone. For this reason, HEXO Corp. (HEXO - Get Rating) may have put production capacity on the back burner until recently. Knowing that HEXO Corp. (HEXO - Get Rating) will be able to distribute more cannabis once they launch their beverage lineup with Molson Coors should push them to acquire more assets to beef up their production capacity. CannTrust would prove to be a valuable asset to HEXOs production capacity instantly more than doubling their numbers with the acquisition.

If HEXO Corp. (HEXO - Get Rating) is really considering buying CannTrust they are still taking some substantial risks if they purchase the company before Health Canada’s decision as to whether CannTrust will maintain their license or not. At the same time, they could miss out on an opportunity to purchase them when their stock is hovering around all-time lows. This past Friday we saw the stock skyrocket to close up 40% on a mere rumor surrounding a buyout, imagine how much CannTrust would take off if Health Canada announces that they will allow them to maintain their license.

I am sure HEXO Corp. (HEXO - Get Rating) is well aware of the risks if they are looking to acquire CannTrust and regardless of whether they will keep their license or not, I feel that a sale of the company is what’s best. HEXO Corp. (HEXO - Get Rating) and CannTrust are both located in Southwestern Ontario which geographically would also benefit the company as CannTrust’s extraction facility is very close to HEXO’s largest growing facility, along with Oakville based newstrike brands. This may be highly speculative but if HEXO Corp. (HEXO - Get Rating) does end up acquiring CannTrust, this could prove to be one of the most strategic buyouts in the cannabis sector and could catapult HEXO Corp. (HEXO - Get Rating) into the top spot.

(Disclosure: The Author is long CannTrust and HEXO)

 


HEXO shares were trading at $4.58 per share on Monday morning, down $0.13 (-2.76%). Year-to-date, HEXO Corp. (HEXO - Get Rating) has gained 33.53%, versus a 16.86% rise in the benchmark S&P 500 index during the same period.


About the Author: Aaron Missere


Aaron is an experienced investors who is also the CEO of Departures Capital. His primary focus is on the cannabis industry. He also hosts a weekly show on YouTube about marijuana stocks. Learn more about Aaron’s background, along with links to his most recent articles. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
HEXOGet RatingGet RatingGet Rating
CGCGet RatingGet RatingGet Rating
ACBGet RatingGet RatingGet Rating
CRONGet RatingGet RatingGet Rating
APHAGet RatingGet RatingGet Rating
TLRYGet RatingGet RatingGet Rating
CTSTGet RatingGet RatingGet Rating

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Top Stories on StockNews.com

NYSE: SPY | SPDR S&P 500 News, Ratings, and Charts

The Biggest Recession Risk We Actually Face

Today's featured article covers the biggest recession risk that we face. Continue reading to find out more details, and how it could affect investors moving forward.
NYSE: HCP | HCP, Inc.  News, Ratings, and Charts

14 Soaring Momentum Stocks

HCP headlines a list of 14 stocks displaying impressive momentum at this time that points to even more upside ahead.
NASDAQ: TLT | iShares 20+ Year Treasury Bond ETF News, Ratings, and Charts

What Does the Options Market Say About Interest Rates?

Why are investors so fixated on interest rates? If you follow the financial markets regularly, you'll notice how laser-focused the investment community is. See how the Options Market is responding to current interest rates.
: CGC | Canopy Growth Corporation  News, Ratings, and Charts

Should Investors Buy the Dip in Canopy Growth (CGC)?

As the entire sector sold off over these past few months, Canopy followed suit sliding from highs of $76 (CAD) all the way down into the $’30s recently.
NYSE: NVS | Novartis AG  News, Ratings, and Charts

Sweet 16 Safe Stocks for this Volatile Market

The bull market is still in place, but appetite for risk is low. Novartis (NVS) is just one of 16 stocks with the right ingredients to excel in this volatile environment.

Read More Stories


More HEXO Corp. Common Shares (hexo) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All hexo News
Page generated in 1.6119 seconds.